CardioSecur introduces 3D-ECG for virtual trials at Clinical Trials Europe
CardioSecur’s ultra-light technology allows your patients to take a 22-lead ECG anytime and anywhere. ©CardioSecur
Barcelona, November 2019. CardioSecur’s 3D 22-lead ECG technology and its patient-centric ecosystem can revolutionize virtual trials. This is why the Frankfurt-based MedTech company will attend the conference for the first time. Clinical Trials Europe conference, previously known as Partnerships in Clinical Trials, has a successful track record of 17 years and will host more than 700 key stakeholders and speakers from November 19 – 21, 2019. It is the premier event for the CRO community and will have an emphasis on virtual and patient-centred trials this year.
The 22-lead ECG-system consists of a lightweight 50g cable with only four electrodes and a mobile app. The interface is very user friendly and intuitively to use as its design was driven by patients. The mobile ECG takes a reading within a few seconds and can help to detect complex arrythmias as well as life-threatening infarctions. Remote patient monitoring, compliance and data administration is made possible through CardioSecur’s Integrated Service Platform (ISP) which seamlessly shares the ECG and additional customized data sets with the researcher’s infrastructure. The proprietary server cluster strictly complies with both the EU-GDPR and Swiss data protection laws and is hosted within the EU. Dynamic study protocols and ECG pre-evaluation help investigators to effectively allocate their resources and keep trials cost efficient.
Learn more about how mobile ECG-technology can help you bring your virtual trial to the next level by visiting CardioSecur’s booth 112A in the emerging services area. We would be delighted to welcome you there!
Additional information at www.cardiosecur.com/trials
Personal MedSystems GmbH
60329 Frankfurt am Main
Phone +49 (0) 151-19120692
Personal MedSystems GmbH develops and sells fully approved medical ECG systems and services for private users, healthcare professionals and aviation corporates under the name CardioSecur.
CardioSecur Active is a cutting edge, clinical-grade 15-lead ECG for personal use. Within a few seconds, it generates personalized feedback regarding changes in the heart’s health. CardioSecur initially records a personal reference ECG to integrate the user’s heart history. This individual “fingerprint of the heart” allows a more accurate evaluation of the current control reading. The simple recommendation to act indicates whether to see a doctor or not. A reading can be taken anytime and anywhere and does not require an internet connection. The entire system consists of a 50g light cable with four electrodes, the complimentary app and the user’s smartphone or tablet.
CardioSecur Pro is the ECG solution for physicians, medical professionals and the aviation sector. CardioSecur Pro is worldwide the first clinical ECG system fully meeting the guidelines of the European Society of Cardiology by providing a 22 lead ECG that operates a 360° evaluation of the heart. It is the only system that thereby identifies infarctions on any wall of the heart and is capable of capturing and localizing even the most complex arrhythmias. ECG sophistication has never before gone any further.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CardioSecur introduces 3D-ECG for virtual trials at Clinical Trials Europe here
News-ID: 1869354 • Views: 497
More Releases from Personal MedSystems GmbH
App-based ECG CardioSecur Now Available in South America
A cooperation between Bambuslife and ANTEL, Uruguay’s largest telecommunications provider, brings the mobile App-based ECG CardioSecur to Uruguay and 20 more countries. Montevideo, December 2019. ANTEL and Bambuslife announced their strategic partnership, which brings the App-based 15-lead ECG CardioSecur to Uruguay and 20 more countries. Both companies were enthusiastic about making the clinically unrivalled ECG technology CardioSecur available in Latin America. Andrés Tolosa, president of ANTEL said: “This is a
CardioSecur® is the Only ECG that Knows the History of your Heart
The heart is just as unique as the fingerprint. That is why every reading with CardioSecur is tailored to every individual user and takes their heart history into account. Frankfurt, April 2019. Cardiovascular diseases are still one of the most common causes of death worldwide, that is why today it is more important than ever to know about one’s heart. The ideal method for detecting heart events is to perform ECG
More Releases for ECG
ECG Cable and ECG Lead Wires Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘ECG Cable and ECG Lead Wires Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the ECG Cable and ECG Lead Wires Market. Increased demand for the technologies is also one of the factors, which are likely to boost
ECG Cable and ECG Lead Wires Market Opportunity Analysis, 2018-2026
Electrocardiograph machines are used to measure the electrical activity of a patient’s heart. The electrical activity of the heart is recorded with the help of 12-lead ECGs and 10 electrodes placed on patient’s limbs and surface of the chest. Furthermore, ECG applies to monitor the patient’s emergency situation to obtain quick results of heart’s size, position of heart chambers, the rate of the heart, rhythm, and any damage to heart
Diagnostic Electrocardiograph (ECG) Market Report 2018: Segmentation by Product …
Global Diagnostic Electrocardiograph (ECG) market research report provides company profile for Fukuda Denshi, Welch Allyn, Mortara Instrument, NIHON KOHDEN, GE Healthcare, Philips, BioTelemetry, Suzuken and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
ECG Cables and ECG Lead Wires Market succouring demand 2025
Global ECG Cables and ECG Lead Wires Market: Snapshot ECG cables and lead wires are a key equipment needed for electrocardiography, a monitoring technique used in several cardiac diseases. The global ECG cables and lead wires market has thus been driven primarily by the rising prevalence of cardiovascular conditions among the modern urban demographic and the growth of the geriatric demographic, which has led to rising demand for cardiac monitoring equipment.
Global ECG cables and ECG leadwires Sales Market industry Report 2017
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global ECG cables and ECG leadwires Sales Market” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Medical Equipments would rise at a positive CAGR during the period 2017-2022.
ECG Equipment & Management System Market Analysis By Type (Holter Monitors, Rest …
Introduction Electrocardiogram (ECG) devices record and test the cardio activity electrically. The electrical impulse that is generated by cardiac tissues is recorded by ECG by polarization and depolarization mechanism. ECG devices are of excessive help to physicians and cardiologist for proper and early detection of cardiac disorders and diagnosis like inflammation of heart, abnormal heart rhythm, congenital heart defect, poor supply of blood to the arteries and many more. ECG stress